BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35729596)

  • 21. Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis.
    Chao D; Hu G; Li Q
    Medicine (Baltimore); 2021 Feb; 100(7):e24748. PubMed ID: 33607820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
    Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
    PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of CXCR4 in ovarian cancer: a meta-analysis.
    Liu CF; Liu SY; Min XY; Ji YY; Wang N; Liu D; Ma N; Li ZF; Li K
    PLoS One; 2014; 9(3):e92629. PubMed ID: 24658065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
    World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological significance of CXCR4 in non-small cell lung cancer.
    Zhou XM; He L; Hou G; Jiang B; Wang YH; Zhao L
    Drug Des Devel Ther; 2015; 9():1349-58. PubMed ID: 25834393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.
    Wang Q; Xu L; Wang G; Chen L; Li C; Jiang X; Gao H; Yang B; Tian W
    PLoS One; 2020; 15(11):e0241241. PubMed ID: 33186371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
    Song Y; Li H; Jiang Q; Wu L
    Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
    Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
    Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
    Wang Y; Wu Y; Li J; Li J; Che G
    Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CXCR4 and non-small cell lung cancer prognosis: a meta-analysis.
    Liu K; Bao C; Yao N; Miao C; Varlotto J; Sun Q; Sun X
    Int J Clin Exp Med; 2015; 8(5):7435-45. PubMed ID: 26221287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
    Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
    Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
    Yang M; Li Y; Tian F
    Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological and prognostic significance of CXCR4 expression in osteosarcoma: a meta-analysis.
    Kusuma IGNAW; Yapson GYA; Nolan J; Wiratnaya IGE; Supadmanaba IGP
    Biomedicine (Taipei); 2022; 12(4):34-43. PubMed ID: 36816176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S; Qiu Z; He J; Li L; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis.
    Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
    Pathol Res Pract; 2020 Apr; 216(4):152849. PubMed ID: 32057516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
    Jiang Q; Sun Y; Liu X
    Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.